TG Therapeutics
A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases
1
Funding Rounds
$25.0m
Money raised
Overview
A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases
-
Website:
- Business model: B2B
- Headquarters: New York
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Da**** Hu** | - | - | |
| Sa*** Lo**** | - | - | |
| Ke Ho* | - | - | - |
| Ya** Ec* | - | - | |
| La* N. Ch | - | - | - |
Funding series
Funding Series Analysis
The company TG Therapeutics has raised a total of $25m in funding over 1 rounds.
Key Insights:
- TG Therapeutics Series A round: $25m
TG Therapeutics Series A round
$25m
Industries
TG Therapeutics is active in the following industries: